TuisPFE • NYSE
add
Pfizer Inc
Vorige sluiting
$26,67
Dagwisseling
$26,58 - $27,30
Jaarwisseling
$21,97 - $28,75
Markkapitalisasie
153,59 mjd USD
Gemiddelde volume
37,12 m
P/V-verhouding
19,91
Dividend-opbrengs
6,37%
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 17,56 mjd | -1,16% |
Bedryfskoste | 8,29 mjd | -9,95% |
Netto inkomste | -1,65 mjd | -501,95% |
Netto winsgrens | -9,39 | -506,49% |
Wins per aandeel | 0,66 | 4,76% |
EBITDA | 5,86 mjd | 52,95% |
Effektiewe belastingkoers | 0,12% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 13,60 mjd | -33,60% |
Totale bates | 208,16 mjd | -2,45% |
Totale aanspreeklikheid | 121,38 mjd | -2,81% |
Totale ekwiteit | 86,78 mjd | — |
Uitstaande aandele | 5,69 mjd | — |
Prys om te bespreek | 1,75 | — |
Opbrengs op bates | 5,04% | — |
Opbrengs op kapitaal | 6,79% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -1,65 mjd | -501,95% |
Kontant van bedrywe | 5,35 mjd | -20,43% |
Kontant van beleggings | -6,15 mjd | -278,68% |
Kontant van finansiering | 596,00 m | 111,65% |
Netto kontantverandering | -197,00 m | -337,78% |
Beskikbare kontantvloei | 7,06 mjd | -5,04% |
Meer oor
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2024, 61% of the company's revenues came from the United States, 4% came from China, and 35% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
Gestig
1849
Webwerf
Werknemers
75 000
